Healthline: Why This FDA-Approved Drug for Pre-Term Birth is being Pulled From the Market
Sarah McBane, Health Sciences Clinical Professor, comments on Makena, the only FDA-approved drug to help reduce preterm labor risk, being withdrawn from the market.
Click to read more.